On Tuesday, Fractyl Health Inc (NASDAQ: GUTS) opened higher 15.61% from the last session, before settling in for the closing price of $0.99. Price fluctuations for GUTS have ranged from $0.87 to $7.89 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -4.50% annually for the last half of the decade. Company’s average yearly earnings per share was noted 10.08% at the time writing. With a float of $20.86 million, this company’s outstanding shares have now reached $48.76 million.
In an organization with 107 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -10.75%, operating margin of -100570.97%, and the pretax margin is -73864.52%.
Fractyl Health Inc (GUTS) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Fractyl Health Inc is 57.37%, while institutional ownership is 34.81%. The most recent insider transaction that took place on Mar 14 ’25, was worth 22,980. In this transaction Director of this company bought 17,901 shares at a rate of $1.28, taking the stock ownership to the 17,901 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 31,000 for $1.30, making the entire transaction worth $40,210. This insider now owns 31,000 shares in total.
Fractyl Health Inc (GUTS) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.51% during the next five years compared to -12.32% drop over the previous five years of trading.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Check out the current performance indicators for Fractyl Health Inc (GUTS). In the past quarter, the stock posted a quick ratio of 3.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 625.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.48 in the next quarter and is forecasted to reach -1.65 in one year’s time.
Technical Analysis of Fractyl Health Inc (GUTS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.41 million. That was better than the volume of 0.3 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 52.15%. Additionally, its Average True Range was 0.11.
During the past 100 days, Fractyl Health Inc’s (GUTS) raw stochastic average was set at 15.31%, which indicates a significant decrease from 62.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 88.57% in the past 14 days, which was higher than the 83.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3364, while its 200-day Moving Average is $2.3481. However, in the short run, Fractyl Health Inc’s stock first resistance to watch stands at $1.1967. Second resistance stands at $1.2433. The third major resistance level sits at $1.3367. If the price goes on to break the first support level at $1.0567, it is likely to go to the next support level at $0.9633. The third support level lies at $0.9167 if the price breaches the second support level.
Fractyl Health Inc (NASDAQ: GUTS) Key Stats
There are currently 48,920K shares outstanding in the company with a market cap of 56.26 million. Presently, the company’s annual sales total 90 K according to its annual income of -68,690 K. Last quarter, the company’s sales amounted to 10 K and its income totaled -23,170 K.
